← Evidence map

ReviewCurrent rheumatology reports2017

Medication Risk Communication in Rheumatology: Where Are We and Where Do We Go from Here?

Susan J BlalockPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 28164248